Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05659836 · ClinicalTrials.gov registry record

Spinal Cord Stimulation Trial to Permanent Prediction

A clinical trial, sponsored by Abbott Medical Devices.

Completed
Registry status
28
Enrollment target

NCT05659836 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 28 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05659836 has completed, sponsored by Abbott Medical Devices.

COMPLETED
Registry status
28 participants
Enrollment target

Study Summary

Spinal Cord Stimulation Trial to Permanent Prediction is a prospective, longitudinal, multi-center, non-randomized, multi-arm, open-label, clinical feasibility study designed to investigate whether objective data collected from chronic pain patients is predictive of subjective patient-reported outcomes and of adjustments to patient programming parameters.

Interventions

  • DEVICE Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring)

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2021-05-27
Est. Completion 2023-06-15

Sponsor

Abbott Medical Devices

261 total trials

What the Registry Record Tells You About NCT05659836

The ClinicalTrials.gov registry entry for NCT05659836 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring) is the first listed.

NCT05659836 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05659836 about?

NCT05659836 is a clinical study titled "Spinal Cord Stimulation Trial to Permanent Prediction". Spinal Cord Stimulation Trial to Permanent Prediction is a prospective, longitudinal, multi-center, non-randomized, multi-arm, open-label, clinical feasibility study designed to investigate whether objective data collected from chronic pain patients is predictive of subjective patient-reported outco...

What is the current status of trial NCT05659836?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2021-05-27. Estimated completion is 2023-06-15.

What interventions are being tested in trial NCT05659836?

The interventions under investigation include: Abbott Spinal Cord Stimulation (SCS) Systems (Apple Watch® & Oura™ Ring) (DEVICE).

Who is sponsoring clinical trial NCT05659836?

This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.